BACTROBAN- mupirocin calcium ointment 
Glaxo Opoerations UK Ltd

----------

BACTROBAN NASAL®
(mupirocin calcium ointment, 2%)
for intranasal use only

Principal Display Panel

NDC 0029-1526-11

BACTROBAN (mupirocin calcium)

Nasal Ointment, 2%

10 x 1.0 gram Single-Use Tubes

This shrink-wrapped unit represents one 5-day course of therapy.

Store at 20o - 25oC (68o – 77oF); excursions permitted 15o - 30oC (59o – 86oF). Do not refrigerate.

Do not use if seal on tube nozzle is broken.

Usual Dosage: For intranasal use only. Apply one-half the contents of a tube in one nostril. Apply other half of tube contents in other nostril. See accompanying prescribing information.

GlaxoSmithKline

Research Triangle Park, NC 27709

 
10000000136205 Rev. 8/15
Bactroban Nasal 10 count label
BACTROBAN 
mupirocin calcium ointment
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:63379-002
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MUPIROCIN CALCIUM (UNII: RG38I2P540) (MUPIROCIN - UNII:D0GX863OA5) MUPIROCIN20 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
PARAFFIN (UNII: I9O0E3H2ZE)  
Product Characteristics
ColorWHITE (white to off-white) Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:63379-002-0210 in 1 PACKAGE04/10/1996
1NDC:63379-002-011 in 1 CARTON
11 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Approved Drug Product Manufactured Under ContractNDA05070304/10/1996
Labeler - Glaxo Opoerations UK Ltd (424738227)
Registrant - GlaxoSmithKline LLC (167380711)

Revised: 11/2017
Document Id: ba22947d-5a4b-4977-ab03-134993ab1682
Set id: f7023609-2f93-41d7-a622-48f36d69d12f
Version: 3
Effective Time: 20171129
 
Glaxo Opoerations UK Ltd